Suppr超能文献

DNA 甲基转移酶 1 对于结肠癌的发生是必不可少的。

DNA methyltransferase 1 is essential for initiation of the colon cancers.

机构信息

Department of Pathology, Sapporo Medical University School of Medicine, South-1 West-17, Chuo-Ku, Sapporo 060-8556, Japan.

出版信息

Exp Mol Pathol. 2013 Apr;94(2):322-9. doi: 10.1016/j.yexmp.2012.10.004. Epub 2012 Oct 9.

Abstract

DNA methyltransferase 1 (Dnmt1) is essential for the maintenance of hematopoietic and somatic stem cells in mice; however, its roles in human cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) are still elusive. In the present study, we investigated DNMT1 functions in the maintenance of human colon CSCs/CICs using the human colon cancer cell line HCT116 (HCT116 w/t) and its DNMT1 knockout cell line (DNMT1(-/-)). The rates of CSCs/CICs were evaluated by side population (SP) analysis, ALDEFLUOR assay and expression of CD44 and CD24. SP, ALDEFLUOR-positive (ALDEFLUOR(+)) and CD44-positive and CD24-positive (CD44(+)CD24(+)) cell rates were lower in DNMT1(-/-) cells than in HCT116 w/t cells. Since CSCs/CICs have higher tumor-initiating ability than that of non-CSCs/CICs, the tumor-initiating abilities were addressed by injecting immune deficient (NOD/SCID) mice. DNMT1(-/-) cells showed less tumor-initiating ability than did HCT116 w/t cells, whereas the growing rate of DNMT1(-/-) cells showed no significant difference from that of HCT116 cells both in vitro and in vivo. Similar results were obtained for cells in which DNMT1 had been transiently knocked-down using gene-specific siRNAs. Taken together, these results indicate that DNMT1 is essential for maintenance of colon CSCs/CICs and that short-term suppression of DNMT1 might be sufficient to disrupt CSCs/CICs.

摘要

DNA 甲基转移酶 1(Dnmt1)对于维持小鼠造血和体干细胞至关重要;然而,其在人类癌症干细胞样细胞(CSC)/癌症起始细胞(CIC)中的作用仍不清楚。在本研究中,我们使用人结肠癌细胞系 HCT116(HCT116 w/t)及其 DNA 甲基转移酶 1 缺失细胞系(DNMT1(-/-))研究了 DNMT1 在维持人结肠 CSC/CIC 中的作用。通过侧群(SP)分析、ALDEFLUOR 测定和 CD44 和 CD24 的表达评估 CSC/CIC 的比率。DNMT1(-/-)细胞中的 SP、ALDEFLUOR 阳性(ALDEFLUOR(+))和 CD44 阳性和 CD24 阳性(CD44(+)CD24(+))细胞比率低于 HCT116 w/t 细胞。由于 CSC/CIC 比非 CSC/CIC 具有更高的肿瘤起始能力,因此通过注射免疫缺陷(NOD/SCID)小鼠来评估肿瘤起始能力。与 HCT116 w/t 细胞相比,DNMT1(-/-)细胞显示出较低的肿瘤起始能力,而在体外和体内,DNMT1(-/-)细胞的生长速度与 HCT116 细胞没有显著差异。使用基因特异性 siRNA 瞬时敲低 DNMT1 的细胞也获得了类似的结果。总之,这些结果表明 DNMT1 对于维持结肠 CSC/CIC 是必不可少的,并且短期抑制 DNMT1 可能足以破坏 CSC/CIC。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验